• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经纤维瘤蛋白募集因子Spred1的EVH1结构域的核磁共振共振归属

NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.

作者信息

Führer Sebastian, Ahammer Linda, Ausserbichler Angela, Scheffzek Klaus, Dunzendorfer-Matt Theresia, Tollinger Martin

机构信息

Center for Molecular Biosciences Innsbruck (CMBI), Institute of Organic Chemistry, University of Innsbruck, Innrain 80/82, 6020, Innsbruck, Austria.

Division of Biological Chemistry, Biocenter, Medical University of Innsbruck, Innrain 80/82, 6020, Innsbruck, Austria.

出版信息

Biomol NMR Assign. 2017 Oct;11(2):305-308. doi: 10.1007/s12104-017-9768-1. Epub 2017 Aug 22.

DOI:10.1007/s12104-017-9768-1
PMID:28831766
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5594049/
Abstract

Neurofibromin and Sprouty-related EVH1 domain-containing protein 1 (Spred1) both act as negative regulators of the mitogen-activated protein kinase pathway and are associated with the rare diseases Neurofibromatosis type 1 and Legius syndrome, respectively. Spred1 recruits the major GTPase activating protein (GAP) neurofibromin from the cytosol to the membrane in order to inactivate the small G protein Ras. These functions are dependent on the N-terminal EVH1 domain and the C-terminal Sprouty domain of Spred1 whereas the former specifically recognizes the GAP related domain of neurofibromin and the latter is responsible for membrane targeting. Within the GAP domain, Spred1 binding depends on the GAPex portion which is dispensable for Ras inactivation. In a first step towards the characterization of the Neurofibromin Spred1 interface in solution we assigned backbone and side chain H, C, and N chemical shifts of the Spred1 derived EVH1 domain. Our chemical shift data analysis indicate seven consecutive β-strands followed by a C-terminal α-helix which is in agreement with the previously reported crystal structure of Spred1(EVH1). Our data provide a framework for further analysis of the function of patient-derived mutations associated with rare diseases.

摘要

神经纤维瘤蛋白和含Sprouty相关EVH1结构域蛋白1(Spred1)均作为丝裂原活化蛋白激酶途径的负调节因子,分别与罕见疾病1型神经纤维瘤病和Legius综合征相关。Spred1将主要的GTP酶激活蛋白(GAP)神经纤维瘤蛋白从细胞质募集到细胞膜,从而使小G蛋白Ras失活。这些功能依赖于Spred1的N端EVH1结构域和C端Sprouty结构域,前者特异性识别神经纤维瘤蛋白的GAP相关结构域,后者负责膜靶向。在GAP结构域内,Spred1的结合取决于对Ras失活可有可无的GAPex部分。作为在溶液中表征神经纤维瘤蛋白Spred1界面的第一步,我们确定了Spred1衍生的EVH1结构域的主链和侧链H、C和N化学位移。我们的化学位移数据分析表明有七个连续的β链,接着是一个C端α螺旋,这与先前报道的Spred1(EVH1)晶体结构一致。我们的数据为进一步分析与罕见疾病相关的患者来源突变的功能提供了框架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d6/5594049/b9b775145f26/12104_2017_9768_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d6/5594049/5773f981d1dd/12104_2017_9768_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d6/5594049/b9b775145f26/12104_2017_9768_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d6/5594049/5773f981d1dd/12104_2017_9768_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d6/5594049/b9b775145f26/12104_2017_9768_Fig2_HTML.jpg

相似文献

1
NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.神经纤维瘤蛋白募集因子Spred1的EVH1结构域的核磁共振共振归属
Biomol NMR Assign. 2017 Oct;11(2):305-308. doi: 10.1007/s12104-017-9768-1. Epub 2017 Aug 22.
2
Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.Ras-ERK信号通路负调节因子SPRED1蛋白的一个结构域与神经纤维瘤蛋白的GTP酶激活蛋白相关结构域之间的相互作用与Legius综合征和1型神经纤维瘤病有关。
J Biol Chem. 2016 Feb 12;291(7):3124-34. doi: 10.1074/jbc.M115.703710. Epub 2015 Dec 3.
3
The neurofibromin recruitment factor Spred1 binds to the GAP related domain without affecting Ras inactivation.神经纤维瘤蛋白募集因子Spred1与GAP相关结构域结合,而不影响Ras失活。
Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):7497-502. doi: 10.1073/pnas.1607298113. Epub 2016 Jun 16.
4
Pathogenic Mutations Associated with Legius Syndrome Modify the Spred1 Surface and Are Involved in Direct Binding to the Ras Inactivator Neurofibromin.与 Legius 综合征相关的致病性突变会改变 Spred1 表面,并直接参与与 Ras 失活因子神经纤维瘤蛋白的结合。
J Mol Biol. 2019 Sep 6;431(19):3889-3899. doi: 10.1016/j.jmb.2019.07.038. Epub 2019 Aug 8.
5
Structural Insights into the SPRED1-Neurofibromin-KRAS Complex and Disruption of SPRED1-Neurofibromin Interaction by Oncogenic EGFR.结构洞察 SPRED1-神经纤维瘤素-KRAS 复合物和致癌性 EGFR 对 SPRED1-神经纤维瘤素相互作用的破坏。
Cell Rep. 2020 Jul 21;32(3):107909. doi: 10.1016/j.celrep.2020.107909.
6
A shared molecular mechanism underlies the human rasopathies Legius syndrome and Neurofibromatosis-1.Legius 综合征和神经纤维瘤病 1 具有共同的分子发病机制。
Genes Dev. 2012 Jul 1;26(13):1421-6. doi: 10.1101/gad.190876.112.
7
Legius syndrome, an Update. Molecular pathology of mutations in SPRED1.莱吉尤斯综合征最新进展。SPRED1基因突变的分子病理学
Keio J Med. 2013;62(4):107-12. doi: 10.2302/kjm.2013-0002-re. Epub 2013 Dec 10.
8
SPRED proteins provide a NF-ty link to Ras suppression.SPRED 蛋白提供了 NF-ty 链接以抑制 Ras。
Genes Dev. 2012 Jul 15;26(14):1515-9. doi: 10.1101/gad.197434.112.
9
SPRED1 Interferes with K-ras but Not H-ras Membrane Anchorage and Signaling.SPRED1干扰K-ras而非H-ras的膜锚定和信号传导。
Mol Cell Biol. 2016 Sep 26;36(20):2612-25. doi: 10.1128/MCB.00191-16. Print 2016 Oct 15.
10
SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia.SPRED1 是一种 RAS-MAPK 通路抑制剂,可导致 Legius 综合征,它是一种在小儿急性髓细胞白血病中下调的肿瘤抑制因子。
Oncogene. 2015 Jan 29;34(5):631-8. doi: 10.1038/onc.2013.587. Epub 2014 Jan 27.

引用本文的文献

1
SPRED2 loss-of-function causes a recessive Noonan syndrome-like phenotype.SPRED2 功能丧失导致隐性诺南综合征样表型。
Am J Hum Genet. 2021 Nov 4;108(11):2112-2129. doi: 10.1016/j.ajhg.2021.09.007. Epub 2021 Oct 8.
2
SPRED proteins and their roles in signal transduction, development, and malignancy.SPRED 蛋白及其在信号转导、发育和恶性肿瘤中的作用。
Genes Dev. 2020 Nov 1;34(21-22):1410-1421. doi: 10.1101/gad.341222.120.
3
Cytoplasmic DROSHA and non-canonical mechanisms of MiR-155 biogenesis in FLT3-ITD acute myeloid leukemia.

本文引用的文献

1
The neurofibromin recruitment factor Spred1 binds to the GAP related domain without affecting Ras inactivation.神经纤维瘤蛋白募集因子Spred1与GAP相关结构域结合,而不影响Ras失活。
Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):7497-502. doi: 10.1073/pnas.1607298113. Epub 2016 Jun 16.
2
A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.一种在癌症中常见突变的RAS病基因:1型神经纤维瘤病肿瘤抑制基因。
Nat Rev Cancer. 2015 May;15(5):290-301. doi: 10.1038/nrc3911. Epub 2015 Apr 16.
3
SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia.
细胞质 DROSHA 和 FLT3-ITD 急性髓系白血病 miR-155 生物发生的非经典机制。
Leukemia. 2021 Aug;35(8):2285-2298. doi: 10.1038/s41375-021-01166-9. Epub 2021 Feb 15.
SPRED1 是一种 RAS-MAPK 通路抑制剂,可导致 Legius 综合征,它是一种在小儿急性髓细胞白血病中下调的肿瘤抑制因子。
Oncogene. 2015 Jan 29;34(5):631-8. doi: 10.1038/onc.2013.587. Epub 2014 Jan 27.
4
Review and update of SPRED1 mutations causing Legius syndrome.SPRED1 基因突变致 Legius 综合征的研究进展。
Hum Mutat. 2012 Nov;33(11):1538-46. doi: 10.1002/humu.22152. Epub 2012 Aug 1.
5
A shared molecular mechanism underlies the human rasopathies Legius syndrome and Neurofibromatosis-1.Legius 综合征和神经纤维瘤病 1 具有共同的分子发病机制。
Genes Dev. 2012 Jul 1;26(13):1421-6. doi: 10.1101/gad.190876.112.
6
Pleckstrin homology (PH) like domains - versatile modules in protein-protein interaction platforms.pleckstrin homology (PH) 样结构域——蛋白质-蛋白质相互作用平台中的多功能模块。
FEBS Lett. 2012 Aug 14;586(17):2662-73. doi: 10.1016/j.febslet.2012.06.006. Epub 2012 Jun 19.
7
TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts.TALOS+:一种利用核磁共振化学位移预测蛋白质主链扭转角的混合方法。
J Biomol NMR. 2009 Aug;44(4):213-23. doi: 10.1007/s10858-009-9333-z. Epub 2009 Jun 23.
8
Diversity of polyproline recognition by EVH1 domains.由EVH1结构域介导的多聚脯氨酸识别的多样性
Front Biosci (Landmark Ed). 2009 Jan 1;14(3):833-46. doi: 10.2741/3281.
9
Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype.SPRED1基因的种系功能丧失突变会导致1型神经纤维瘤病样表型。
Nat Genet. 2007 Sep;39(9):1120-6. doi: 10.1038/ng2113. Epub 2007 Aug 19.
10
The CCPN data model for NMR spectroscopy: development of a software pipeline.用于核磁共振波谱的CCPN数据模型:软件流程的开发
Proteins. 2005 Jun 1;59(4):687-96. doi: 10.1002/prot.20449.